Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 5.16
1.57 %
$ 108 M
Market Cap
39.69
P/E
CASH FLOW STATEMENT
5.24 M
OPERATING CASH FLOW
-5 M
INVESTING CASH FLOW
-4.8 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Journey Medical Corporation
| Net Income | -3.85 M |
| Depreciation & Amortization | 3.86 M |
| Capital Expenditures | -5 M |
| Stock-Based Compensation | 2.61 M |
| Change in Working Capital | -1.66 M |
| Others | 4.55 M |
| Free Cash Flow | 240 K |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | ||||||||||
| Net Income | (3.9) | (29.6) | (44.0) | 5.3 | 3.6 | (221.5) | (303.3) | (89.1) | (78.4) | (31.9) |
| Depreciation & Amortization | 3.9 | 4.4 | 2.6 | 1.5 | 1.3 | 0.6 | 0.3 | 0.1 | 72 K | 47 K |
| Deferred Income Tax | 0 | 0 | 1.6 | (0.3) | 69 K | (0.2) | 0 | (0.6) | 31 K | 31 K |
| Stock Based Compensation | 2.6 | 4.4 | 2.5 | 0.2 | 0.2 | 29.8 | 20.7 | 0 | 5.1 | 1.6 |
| Other Operating Activities | 4.3 | 1.1 | 20.5 | 0.7 | 0.4 | 132.6 | (24.0) | (53.2) | (73.0) | 0.3 |
| Change in Working Capital | (1.7) | 6.2 | 14.7 | (2.2) | 3.5 | (154.4) | 202.3 | 57.7 | 97.8 | (1.5) |
| Cash From Operations | 5.2 | (13.5) | (2.2) | 5.1 | 9.0 | (213.1) | (104.0) | (74.1) | (48.4) | (31.4) |
| INVESTING CASH FLOW | ||||||||||
| Capital Expenditures | (5.0) | (20.0) | (10.0) | (1.2) | (2.4) | (0.6) | (0.3) | (0.8) | (0.2) | (0.2) |
| Other Items | 0 | 0 | 0 | 0 | 0 | (12.6) | (104.2) | (129.5) | (2.4) | (109.3) |
| Cash From Investing Activities | (5.0) | (20.0) | (10.0) | (1.2) | (2.4) | (13.2) | (104.4) | (130.3) | (2.6) | (109.5) |
| FINANCING CASH FLOW | ||||||||||
| Common Stock Repurchased | 0 | (0.4) | 0 | 0 | 0 | 2.1 | 184.3 | 138.9 | 105.0 | 170.1 |
| Total Debt Repaid | (6.4) | 16.9 | 5.1 | (0.5) | (3.6) | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (2.9) | (0.4) | 35.9 | 13 K | 0 | 35.4 | 462.5 | 138.9 | 102.9 | 174.1 |
| Cash From Financing Activities | (4.8) | 16.5 | 53.0 | (0.5) | (3.6) | 35.4 | 462.5 | 138.9 | 102.9 | 174.1 |
| CHANGE IN CASH | ||||||||||
| Net Change In Cash | (4.6) | (17.1) | 40.8 | 3.4 | 3.1 | (190.9) | 254.1 | (65.4) | 51.9 | 11.1 |
| FREE CASH FLOW | ||||||||||
| Free Cash Flow | 0.2 | (33.5) | (12.2) | 3.9 | 6.6 | (213.7) | (104.2) | (74.9) | (48.6) | (31.6) |